Since 2013, TI Pharma has embarked on a new phase as an independent non-profit that enables international partnership in drug discovery and development.

A number of projects funded by the government’s gas reserve fund (“FES”), either originating from the 2009 Joint Call (JC) or the 2012 SME Partnership Call (SPC) are still running:  

“What TI Pharma can deliver from collaborations is more efficient healthcare, faster time to market and quicker patient benefit.”

Share this page: